Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, efficacy, safety, and immunogenicity of human-cl rhFVIII vs Kogenate/Helixate in severe hemophilia A
2008-001563-11Phase 2Completed
- Sponsor
- Octapharma
- Start
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of simoctocog alfa in hemophilia A (2 arms), sponsored by Octapharma. Primary endpoints: Primary pharmacokinetic comparison (AUC normalized for dose) and Incremental recovery of FVIII:C. Started May 2009; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2008-001563-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001563-11.